Related Experiment Videos

Agonist-specific down-regulation of the human delta-opioid receptor

Takashi Okura1, Eva V Varga, Yoshiaki Hosohata

  • 1Department of Pharmacology, The University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.

Insights

Down-regulation of the delta-opioid receptor is key to tolerance. The receptor's C-terminus is crucial, but SNC80 acts differently, suggesting other domains are involved in its effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Delta-opioid receptor (DOR) down-regulation contributes to tolerance against DOR agonists.
  • The mouse DOR carboxy terminus is implicated in peptide agonist-induced down-regulation.

Purpose of the Study:

  • To investigate the down-regulation of the truncated human DOR by distinct DOR agonists.
  • To elucidate the role of the C-terminus in human DOR down-regulation and signaling.

Main Methods:

  • Chinese hamster ovary (CHO) cells expressing full-length or truncated epitope-tagged human DOR were used.
  • Receptor levels were quantified using [(3)H]naltrindole saturation binding after agonist incubation.
  • Agonist-mediated [(32)P] incorporation into the receptor was assessed.

Main Results:

  • All tested DOR agonists down-regulated the full-length human DOR.
  • Truncation of the C-terminus abolished down-regulation by most agonists, except SNC80.
  • SNC80 induced C-terminal truncation-resistant phosphorylation and down-regulation, independent of G(i/o) proteins.

Conclusions:

  • SNC80-mediated human DOR down-regulation and phosphorylation involve domains beyond the C-terminus.
  • The C-terminus is essential for down-regulation by certain DOR agonists but not SNC80.
  • SNC80's effects on truncated DOR are independent of G(i/o) protein signaling pathways.

Related Concept Videos